Tag Archive for: ALLOB

Clinical development of Bone Therapeutics' lead asset, the bone forming cell therapy ALLOB, will be discontinued. © Pixabay.com/virnuls
CGT

BioSenic halts ALLOB development

BioSenic SA has  suspended its Phase II proof-of-concept trial on fracture healing with its allogeneic cell therapy ALLOB.

Read more